Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5024-5032

  Luketic, Lea ^a   Delanghe, Jordan ^a   Sobol, Paul T ^a   Yang, Pingchang ^a   Frotten, Erin ^a   Mossman, Karen L ^a   Gauldie, Jack ^a   Bramson, Jonathan ^a   Wan, Yonghong ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; EGG PROTEIN; OVA 8; OVA-8; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EXOSOME; FEMALE; IN VIVO CULTURE; LYMPH NODE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; ANIMAL; C57BL MOUSE; CYTOTOXICITY; EXOCYTOSIS; EXPERIMENTAL MELANOMA; IMMUNIZATION; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EGG PROTEINS; EXOCYTOSIS; FEMALE; IMMUNIZATION, SECONDARY; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 38449100732     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5024     Document Type: Article

References (50)

1. Prins, R. M., S. K. Odesa, and L. M. Liau. 2003. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Cancer Res. 63: 8487-8491.
2. + T-cell function in melanoma patients. J. Clin. Oncol. 21: 3826-3835.
3. Brossart, P., S. Wirths, G. Stuhler, V. L. Reichardt, L. Kanz, and W. Brugger. 2000. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96: 3102-3108.
4. Linette, G. P., D. Zhang, F. S. Hodi, E. P. Jonasch, S. Longerich, C. P. Stowell, I. J. Webb, H. Daley, R. J. Soiffer, A. M. Cheung, et al. 2005. Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity. Clin. Cancer Res. 11: 7692-7699.
5. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5: 296-306.
6. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100: 1734-1741.
7. + T cells. J. Exp. Med. 185: 2133-2141.
8. Loyer, V., P. Fontaine, S. Pion, F. Hetu, D. C. Roy, and C. Perreault. 1999. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J. Immunol. 163: 6462-6467.
9. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164: 3095-3101.
10. + T cells in vivo: implications for adaptive immunotherapy. Eur. J. Immunol. 31: 1772-1779.
11. Storni, T., C. Ruedl, W. A. Renner, and M. F. Bachmann. 2003. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J. Immunol. 171: 795-801.
12. Josien, R., H. L. Li, E. Ingulli, S. Sarma, B. R. Wong, M. Vologodskaia, R. M. Steinman, and Y. Choi. 2000. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191: 495-502.
13. Hou, W. S., and L. Van Parijs. 2004. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5: 583-589.
14. Hugues, S., L. Fetler, L. Bonifaz, J. Helft, F. Amblard, and S. Amigorena. 2004. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat. Immunol. 5: 1235-1242.
15. Hanks, B. A., J. Jiang, R. A. Singh, W. Song, M. Barry, M. H. Huls, K. M. Slawin, and D. M. Spencer. 2005. Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. Nat. Med. 11: 130-137.
16. Medema, J. P., D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E. Toes, M. Toebes, T. N. Schumacher, et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194: 657-667.
17. Taieb, J., N. Chaput, and L. Zitvogel. 2005. Dendritic cell-derived exosomes as cell-free peptide-based vaccines. Crit. Rev. Immunol. 25: 215-223.
18. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600.
19. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76: 17-27.
20. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. M. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23: 1956-1962.
21. Prévost-Blondel, A., C. Zimmermann, C. Stemmer, P. Kulmburg, F. M. Rosenthal, and H. Pircher. 1998. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J. Immunol. 161: 2187-2194.
22. + T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
23. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223: 77-92.
24. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172.
25. Lane, C., J. Leitch, X. Tan, J. Hadjati, J. L. Bramson, and Y. Wan. 2004. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res. 64: 1509-1514.
26. Shen, L., and K. L. Rock. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101: 3035-3040.
27. Schartz, N. E., N. Chaput, F. Andre, and L. Zitvogel. 2002. From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes. Curr. Opin. Mol. Ther. 4: 372-381.
28. André, F., N. Chaput, N. E. Schartz, C. Flament, N. Aubert, J. Bernard, F. Lemonnier, G. Raposo, B. Escudier, D. H. Hsu, T. Tursz, et al. 2004. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172: 2126-2136.
29. Théry, C., M. Boussac, P. Véron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318.
30. Théry, C., A. Regnault, J. Garin, J. Wolfers, L. Zitvogel, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1999. Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147: 599-610.
31. Quah, B. J., and H. C. O'Neill. 2005. The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol. Dis. 35: 94-110.
32. Fevrier, B., and G. Raposo. 2004. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16: 415-421.
33. Wong, P., and E. G. Pamer. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity 18: 499-511.
34. Ronchese, F., and I. F. Hermans. 2001. Killing of dendritic cells: a life cut short or a purposeful death? J. Exp. Med. 194: F23-F26.
35. Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Théry, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297-303.
36. Sprent, J. 2005. Direct stimulation of naive T cells by antigen-presenting cell vesicles. Blood Cells Mol. Dis. 35: 17-20.
37. Delcayre, A., H. Shu, and J. B. Le Pecq. 2005. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Expert Rev. Anticancer Ther. 5: 537-547.
38. Admyre, C., S. M. Johansson, S. Paulie, and S. Gabrielsson. 2006. Direct exosome stimulation of peripheral humanT cells detected by ELISPOT. Eur. J. Immunol. 36: 1772-1781.
39. Kovar, M., O. Boyman, X. Shen, I. Hwang, R. Kohler, and J. Sprent. 2006. Direct stimulation of T cells by membrane vesicles from antigen-presenting cells. Proc. Natl. Acad. Sci. USA 103: 11671-11676.
40. Hwang, I., X. Shen, and J. Sprent. 2003. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc. Natl. Acad. Sci. USA 100: 6670-6675.
41. Vincent-Schneider, H., P. Stumptner-Cuvelette, D. Lankar, S. Pain, G. Raposo, P. Benaroch, and C. Bonnerot. 2002. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int. Immunol. 14: 713-722.
42. + T cells by dendritic cell-derived exosomes. Nat. Immunol. 3: 1156-1162.
43. Morelli, A. E., A. T. Larregina, W. J. Shufesky, M. L. Sullivan, D. B. Stolz, G. D. Papworth, A. F. Zahorchak, A. J. Logar, Z. Wang, S. C. Watkins, et al. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
44. Cho, J. A., D. J. Yeo, H. Y. Son, H. W. Kim, D. S. Jung, J. K. Ko, J. S. Koh, Y. N. Kim, and C. W. Kim. 2005. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int. J. Cancer 114: 613-622.
45. Segura, E., C. Nicco, B. Lombard, P. Véron, G. Raposo, F. Batteux, S. Amigorena, and C. Théry. 2005. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106: 216-223.
46. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 286: 952-954.
47. + T helper-antigen-presenting cells. J. Immunol. 174: 7497-7505.
48. Cox, J. H., A. J. McMichael, G. R. Screaton, and X.-N. Xu. 2007. CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs. J. Immunol. 179: 830-836.
49. van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2: 423-429.
50. + T cells in vivo. Proc. Natl. Acad. Sci. USA 103: 147-152.